Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7104632
Reference Type
Journal Article
Title
Conservative multimodal management of osteosynthesis material in surgical wounds with polymicrobial superinfection, including methicillin-resistant Staphylococcus aureus. Clinical case
Author(s)
Losa Palacios, S; Achaerandio de Nova, A; GerĂ³nimo Pardo, M; ,
Year
2019
Is Peer Reviewed?
1
Journal
Revista Espanola de Cirugia Ortopedica y Traumatologia
ISSN:
1888-4415
Volume
64
Issue
2
Page Numbers
125-129
Language
English
PMID
31892471
DOI
10.1016/j.recot.2019.11.001
Abstract
Retentive treatment of prosthetic material superinfected by resistant microorganisms is a challenge, especially when the causative agent is a methicillin-resistant Staphylococcus aureus. We present the successful conservative management of osteosynthesis material implanted due to ankle fracture in an elderly patient who suffered superinfection by the aforementioned microorganism, in which the antimicrobial treatment consisted of the combination of antibiotic-guided systemic antibiotics (after a first ineffective empirical cycle), together with topical irrigations of sevoflurane, applications of silver sulfadiazine cream, and subsequently coverage of the skin defect with negative pressure therapy. We highlight the novel role of sevoflurane as an analgesic and as a topical antimicrobial agent (in addition to silver sulfadiazine) in the favourable evolution of the wound, especially in the period in which the empirical antibiotic therapy was ineffective and negative pressure therapy had not yet been applied.
Tags
•
PFAS 150
Literature Search Update December 2021
PubMed
Missing 2021 searches
Literature Search Update December 2020
PubMed
Literature Search August 2019
PubMed
Not prioritized for screening
1,1,1,3,3,3-Hexafluoro-2- (fluoromethoxy)propane
•
PFAS Universe
Data Source
Pubmed
Sevoflurane
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity